Corcept Therapeutics Inc.
Symbol: CORT (NASDAQ)
72.68
▲ (1.47%) 1.055
Company Description:
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Key Stats
- Today's Open: $71.84
- Today's High: $74.466
- Today's Low: $71.355
- Today's Volume: 718.09K
- Yesterday Close: $71.62
- Yesterday High: $73.59
- Yesterday Low: $71.295
- Yesterday Volume: 615.57K
- Last Min Volume: 1
- Last Min High: $72.675
- Last Min Low: $72.675
- Last Min VWAP: $72.675
Company Profile
- Name: Corcept Therapeutics Inc.
- Website: https://www.corcept.com
- Listed Date: 2004-04-14
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001088856
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $7.55B
- Round Lot: 100
- Outstanding Shares: 105.37M
- Asset Type: CS
RECENT FILINGS FOR CORT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-10 | 144 | View |
| 2025-09-10 | 8-K | View |
| 2025-09-08 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-09-02 | 144 | View |
| 2025-09-02 | 144 | View |
| 2025-09-02 | 144 | View |
| 2025-08-26 | 4 | View |
| 2025-08-22 | 144 | View |
| 2025-08-12 | 4 | View |
| 2025-08-12 | 4 | View |
| 2025-08-11 | 144 | View |
Latest News on CORT